![](/img/cover-not-exists.png)
PDB12 COST-MINIMIZATION ANALYSIS OF INSULIN LISPRO 50/50 VERSUS INSULIN ASPART 30/70 PREMIXED FORMULATIONS IN TYPE II DIABETES
Yousefi, N., Taheri, S., Sheikhi, S., Amani, B., Akbarzadeh, A., Peiravian, F.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.894
Date:
November, 2019
File:
PDF, 654 KB
2019